Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets, manufactured by Sun Pharmaceuticals Ltd., is a specialized medication designed for the treatment of blood cancer, offering targeted therapy for specific types of leukemia.
Uses of Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets are indicated for:
Treatment of chronic myeloid leukemia (CML) in adults.
Management of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in adults and pediatric patients.
Benefits of Nelova (Nilotinib) 200mg Tablets
Targets and inhibits specific proteins responsible for the growth and survival of cancer cells.
Improves progression-free survival and overall survival rates in patients with CML and Ph+ ALL.
Provides a well-tolerated oral treatment option, enhancing convenience and adherence to therapy.
Mechanism of Action of Nelova (Nilotinib) 200mg Tablets
Nelova (Nilotinib) 200mg Tablets contain nilotinib, a tyrosine kinase inhibitor that selectively inhibits BCR-ABL, c-KIT, and PDGFR kinases. By blocking these signaling pathways, nilotinib prevents the proliferation and survival of leukemia cells, leading to disease regression and improved clinical outcomes.